drugset / Trial / NCT06444529

A Double-Masked Comparison of FID 123320 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness

NCT06444529

Phase 3 Completed 159 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the safety and efficacy of Apraclonidine Hydrochloride Ophthalmic Solution 0.125% when compared to Vehicle, in relieving redness of the eye due to minor eye irritations. This study will be conducted in the United States.

Timeline

Start
2024-08-21
Primary completion
2024-11-14
Completion
2025-01-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Apraclonidine Small molecule 0.125 % Topical

Indications